RELV / Reliv' International, Inc. - SEC-arkiveringer, Årsrapport, Fullmaktsdokument

- SCHEDULE 13E3/A

SC 13E3/A 1 relv20210115sc13e3a.htm SCHEDULE 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3/A (Rule 13e-100) (Amendment No. 3-Final Amendment) RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 RELIV INTERNATIONAL, INC. (Name of the Issuer) RELIV INTERNATIONAL, INC. ROBERT L. MONTGOMERY STEPHEN M. MERRICK (Name

- FORM 15-12G

15-12G 1 relv202101151512g.htm FORM 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES AND EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-19932 RELIV INTERNATIONAL, IN

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commi

- FORM 25

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-19932 RELIV INTERNATIONAL, INC. THE NASDAQ STOCK MARKET LLC (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Reliv International, Inc. Announces Update to its Reverse Stock Split Transaction and Plan to Delist from NASDAQ and Deregister its Common Stock

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International, Inc. Announces Update to its Reverse Stock Split Transaction and Plan to Delist from NASDAQ and Deregister its Common Stock CHESTERFIELD, MO, December 4, 2020 – Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

8-K 1 relv202012048k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorpora

- SCHEDULE 13E3/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3/A (Rule 13e-100) (Amendment No. 2) RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 RELIV INTERNATIONAL, INC. (Name of the Issuer) RELIV INTERNATIONAL, INC. ROBERT L. MONTGOMERY STEPHEN M. MERRICK (Name of Person(s) Filing Statement) Common Stock, par value $0.001 per s

- FORM DEF 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)2)) ☒ Definitive Information Statement RELIV INTERNATIONAL, INC. (Name of Re

- FORM PRER14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)2)) ☐ Definitive Information Statement RELIV INTERNATIONAL, INC. (Name of Re

- FORM PRER14C

PRER14C 1 relv20201118bprer14c.htm FORM PRER14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)2)) ☐ Definitive Information

- SCHEDULE 13E3/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3/A (Rule 13e-100) (Amendment No. 1) RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 RELIV INTERNATIONAL, INC. (Name of the Issuer) RELIV INTERNATIONAL, INC. ROBERT L. MONTGOMERY STEPHEN M. MERRICK (Name of Person(s) Filing Statement) Common Stock, par value $0.001 per s

-

Reliv International, Inc. 136 Chesterfield Industrial Blvd. Chesterfield, MO 63005 November 17, 2020 Via EDGAR Mr. Valian A. Afshar Special Counsel Office of Mergers and Acquisitions Securities and Exchange Commission Division of Corporation Finance Washington, DC 20549 Re: Reliv? International, Inc. Preliminary Information Statement on Schedule 14C Filed on October 21, 2020 File No. 0-19932 Sched

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commi

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

Reliv International Reports Third-Quarter Financial Results for 2020

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results for 2020 CHESTERFIELD, MO, November 13, 2020 – Reliv International, Inc. (NASDAQ:RELV), a marketer of nutritional supplements that promote optimal health, today reported its financial results for the th

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

Loan Agreement between Enterprise Bank and Trust and Reliv International, Inc., Reliv World Corporation, Reliv, Inc., SL Technology, Inc., and Chesterfield Partners LLC dated November 5, 2020 (filed herewith).

EX-10.1 2 ex212481.htm EXHIBIT 10.1 Exhibit 10.1 LOAN AGREEMENT THIS LOAN AGREEMENT, dated as of November 5, 2020, is made and entered into by and among RELIV’, INC., an Illinois corporation, RELIV’ INTERNATIONAL, INC., a Delaware corporation, RELIV’ WORLD CORPORATION, an Illinois corporation, SL TECHNOLOGY, INC., a Missouri corporation, and CHESTERFIELD PARTNERS LLC, a Missouri limited liability

Promissory Note between Enterprise Bank and Trust and Reliv International, Inc., Reliv World Corporation, Reliv, Inc., SL Technology, Inc., and Chesterfield Partners LLC dated November 5, 2020 (filed herewith).

EX-10.2 3 ex212482.htm EXHIBIT 10.2 Exhibit 10.2 PROMISSORY NOTE $4,000,000.00 November 5, 2020 FOR VALUE RECEIVED, the undersigned, RELIV’, INC., an Illinois corporation, RELIV’ INTERNATIONAL, INC., a Delaware corporation, RELIV’ WORLD CORPORATION, an Illinois corporation, SL TECHNOLOGY, INC., a Missouri corporation, and CHESTERFIELD PARTNERS LLC, a Missouri limited liability company (collectivel

- SCHEDULE 13E3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3 (Rule 13e-100) RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 RELIV INTERNATIONAL, INC. (Name of the Issuer) RELIV INTERNATIONAL, INC. (Name of Person(s) Filing Statement) Common Stock, par value $0.001 per share (Title of Class of Securities) 75952 R 209 (CUSIP Numbe

- FORM PRE 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)2)) ☐ Definitive Information Statement RELIV INTERNATIONAL, INC. (Name of Re

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

8-K 1 relv202010168k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorpora

RELIV INTERNATIONAL, INC. SUMMARY OF “REVERSE STOCK SPLIT” TRANSACTION

EX-99.2 3 ex207312.htm EXHIBIT 99.2 Exhibit 99.2 RELIV INTERNATIONAL, INC. SUMMARY OF “REVERSE STOCK SPLIT” TRANSACTION Overview The Board of Directors of Reliv International, Inc., a Delaware corporation (the "Company" or “we”), approved resolutions proposing amendments to our Certificate of Incorporation (the "Certificate of Incorporation") to effect a reverse stock split of our Common Stock fol

RELIV INTERNATIONAL, INC. ANNOUNCES REVERSE STOCK SPLIT TRANSACTION AND PLAN TO DELIST FROM NASDAQ AND DEREGISTER ITS COMMON STOCK

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION RELIV INTERNATIONAL, INC. ANNOUNCES REVERSE STOCK SPLIT TRANSACTION AND PLAN TO DELIST FROM NASDAQ AND DEREGISTER ITS COMMON STOCK CHESTERFIELD, MO, October 19, 2020 – Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements t

Reliv International Reports Second-Quarter Financial Results for 2020

EX-99.1 2 ex199557.htm EXHIBIT 99.1 Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results for 2020 CHESTERFIELD, MO, August 14, 2020 – Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements that promote optimal health

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 relv202008138k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporat

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

- FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 1

Quarterly Report - FORM 10-Q

10-Q 1 relv2020033110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Comm

Reliv International Reports First-Quarter Financial Results for 2020

EX-99.1 2 ex186819.htm EXHIBIT 99.1 Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2020 CHESTERFIELD, MO, May 15, 2020 – Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements that promote optimal health, to

Change in Terms Agreement (revolving credit facility) dated April 28, 2020 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (filed herewith).

EX-10.1 2 ex185804.htm EXHIBIT 10.1 Exhibit 10.1

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 relv202005148k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation

Promissory Note between Enterprise Bank and Trust and Reliv International, Inc. dated April 20, 2020.

EX-10.1 2 ex184952.htm EXHIBIT 10.1 Exhibit 10.1

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K 1 relv202005058k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation)

Subsidiaries of the Registrant (filed herewith).

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S. de R.L. de C.V., organized under the laws of

RELV / Reliv' International, Inc. 10-K - Annual Report - FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2019

EX-99.1 2 ex179168.htm EXHIBIT 99.1 Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2019 CHESTERFIELD, MO, March 27, 2020 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, to

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 relv202003268k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporati

RELV / Reliv' International, Inc. POS AM - - FORM POS AM

As filed with the Securities and Exchange Commission on December 27, 2019 SEC Registration No.

RELV / Reliv' International, Inc. S-8 POS - - FORM S-8 POS

As filed with the Securities and Exchange Commission on December 27, 2019 Registration No.

RELV / Reliv' International, Inc. POS AM - - FORM POS AM

As filed with the Securities and Exchange Commission on December 27, 2019 SEC Registration No.

RELV / Reliv' International, Inc. S-8 POS - - FORM S-8 POS

S-8 POS 1 relv20191226bs8pos.htm FORM S-8 POS As filed with the Securities and Exchange Commission on December 27, 2019 Registration No. 333-67921 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 POST EFFECTIVE AMENDMENT NO. 1 TO REGISTRATION STATEMENT ON FORM S-8 UNDER THE SECURITIES ACT OF 1933 RELIV INTERNATIONAL, INC. (Exact name of registrant as specified in its charter)

RELV / Reliv' International, Inc. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

Reliv International Reports Third-Quarter Financial Results for 2019

EX-99.1 2 ex164809.htm EXHIBIT 99.1 Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results for 2019 CHESTERFIELD, MO, November 14, 2019 – Reliv International, Inc. (NASDAQ:RELV), a marketer of nutritional supplements that promote optimal health, today repor

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 relv201911138k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2019 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorpor

Agreement dated June 1, 2019 with Nutracom, LLC to modify Purchase Agreement and Secured Promissory Note dated January 1, 2019 (filed herewith).

EX-10.1 2 ex154249.htm EXHIBIT 10.1 Exhibit 10.1 AGREEMENT Agreement by and between Nutracom, LLC, a Missouri limited liability company (“Nutracom”), and Reliv International, Inc., a Delaware corporation (“Reliv”), entered into this first day of June, 2019. RECITALS WHEREAS, Nutracom and Reliv entered into a purchase agreement dated January 1, 2019 (the “Purchase Agreement”) whereby Reliv sold to

RELV / Reliv' International, Inc. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of theSecurities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2019 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

Reliv International Reports Second-Quarter Financial Results for 2019

EX-99.1 2 ex154081.htm EXHIBIT 99.1 Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results for 2019 CHESTERFIELD, MO, August 9, 2019 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported i

RELV / Reliv' International, Inc. 11-K - - FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 1

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2019 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

RELV / Reliv' International, Inc. 10-Q Quarterly Report FORM 10-Q

10-Q 1 relv2019033110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Comm

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2019 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

Reliv International Reports First-Quarter Financial Results for 2019

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2019 CHESTERFIELD, MO, May 10, 2019 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the first quar

RELV / Reliv' International, Inc. FORM DEF 14A

DEF 14A 1 relv20190403def14a.htm FORM DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2018

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2018 CHESTERFIELD, MO, March 29, 2019 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results f

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2019 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

Unsecured Term Note issued by Nutracom, LLC to Registrant dated January 1, 2019 (filed herewith).

EX-10.28 6 ex138961.htm EXHIBIT 10.28 Exhibit 10.28 UNSECURED TERM NOTE $764,343.51 January 1, 2019 This UNSECURED TERM NOTE is executed and delivered under and pursuant to that certain Purchase Agreement dated as of the date hereof by and among Reliv International, Inc., a Delaware corporation (“Company”) and Nutracom, LLC, a Missouri limited liability company (“Maker”). FOR VALUE RECEIVED, Maker

Change in Terms Agreement (revolving credit facility) dated March 25, 2019 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (filed herewith).

Exhibit 10.30

Subsidiaries of the Registrant (filed herewith).

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

Carl W. Hastings Employment Agreement dated January 1, 2019 (filed herewith).

Exhibit 10.3 EMPLOYMENT AGREEMENT THIS AGREEMENT is made and entered into this 1st day of January, 2019, by and between Reliv' International, Inc., a Delaware corporation (the “Company”), and Carl W. Hastings (hereinafter referred to as the “Executive”). WHEREAS, the Executive is presently, and for some time has been, employed as an Executive of the Company, pursuant to the terms of an Employment

Fourth Amendment to Loan Agreement dated March 25, 2019 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (filed herewith)

Exhibit 10.29

Lease between Registrant (lessor) and Nutracom, LLC (lessee) dated January 1, 2019 (filed herewith).

Exhibit 10.26 LEASE To Nutracom, LLC 138 Chesterfield Industrial Boulevard Chesterfield, MO 63005 January 1, 2019 Page 1 of 22 REFERENCE PAGE OF LEASE DATE OF LEASE: January 1, 2019 BUILDING: as shown on Exhibit “A” LESSOR: Reliv International, Inc. LESSOR’S ADDRESS: 136 Chesterfield Industrial Boulevard Chesterfield, MO 63005 LESSOR’S PHONE: (636) 733-1410 LESSOR’S CONTACT: Ryan A. Montgomery, Ch

RELV / Reliv' International, Inc. FORM 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF

Secured Term Note issued by Nutracom, LLC to Registrant dated January 1, 2019 (filed herewith).

Exhibit 10.27 SECURED TERM NOTE $1,000,000 January 1, 2019 This SECURED TERM NOTE is executed and delivered under and pursuant to that certain Purchase Agreement dated as of the date hereof by and among Reliv International, Inc., a Delaware corporation (“Company”) and Nutracom, LLC, a Missouri limited liability company (“Maker”). FOR VALUE RECEIVED, Maker hereby promises to pay to the Company at t

Purchase Agreement with Nutracom, LLC dated January 1, 2019 (filed herewith).

Exhibit 2.1 PURCHASE AGREEMENT Nutracom, LLC, a Missouri limited liability company (“Nutracom”), and Reliv International, Inc., a Delaware corporation (“Reliv”), enter into this Purchase Agreement for the purchase and sale of certain assets of the Nutracom Division of Reliv (the “Business”). RECITALS WHEREAS, the Nutracom and Reliv have completed negotiations regarding Nutracom’s proposed purchase

Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 1, 2019 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

RELV / Reliv' International, Inc. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

Change in Terms Agreement (revolving credit facility) dated September 11, 2018 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.2 to the Form 10-Q of the Registrant filed November 14, 2018).

Exhibit 10.2

Third Amendment to Loan Agreement dated September 11, 2018 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.1 to the Form 10-Q of the Registrant filed November 14, 2018).

Exhibit 10.1

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

Reliv International Reports Third-Quarter Financial Results for 2018

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results for 2018 CHESTERFIELD, MO, November 9, 2018 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the third

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

RELV / Reliv' International, Inc. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

Reliv International Reports Second-Quarter Financial Results for 2018

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results for 2018 CHESTERFIELD, MO, August 10, 2018 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the second

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

Reliv International Announces Executive Promotions

Exhibit 99.1 PRESS RELEASE Media Contact: Kurt Wulff [email protected] 636-733-1433 Reliv International Announces Executive Promotions CHESTERFIELD, MO, July 2, 2018 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promotes optimal health, today announced a series of internal executive promotions. Tom Pinnock to President of Sales and Marketing For over three de

Financial Statements and Exhibits

8-K 1 relv201807028k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation

RELV / Reliv' International, Inc. FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 1

Reliv International Names Ryan Montgomery Chief Executive Officer

Exhibit 99.1 PRESS RELEASE Media Contact: Kurt Wulff [email protected] 636-733-1433 Reliv International Names Ryan Montgomery Chief Executive Officer CHESTERFIELD, MO, June 6, 2018 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promotes optimal health, today announced that its Board of Directors has appointed Ryan A. Montgomery to the position of Chief Executi

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

RELV / Reliv' International, Inc. FORM 10-Q (Quarterly Report)

10-Q 1 relv2018033110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Comm

Change in Terms Agreement (term loan) dated April 11, 2018 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (filed herewith).

Exhibit 10.2

Change in Terms Agreement (revolving credit facility) dated April 30, 2018 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.3 to the Form 10-Q of the Registrant filed May 15, 2018).

Exhibit 10.3

Second Amendment to Loan Agreement dated April 11, 2018 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.1 to the Form 10-Q of the Registrant filed May 15, 2018).

Exhibit 10.1

Reliv International Reports First-Quarter Financial Results for 2018

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2018 CHESTERFIELD, MO, May 11, 2018 – Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

RELV / Reliv' International, Inc. FORM DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

RELV / Reliv' International, Inc. FORM 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2017 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13

Subsidiaries of the Registrant (filed herewith).

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

RELV / Reliv' International, Inc. FORM 8-K (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2017

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2017 CHESTERFIELD, MO, March 27, 2018 – Reliv International, Inc.

RELV / Reliv' International, Inc. / Montgomery Robert L - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 RELIV INTERNATIONAL INC. (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 75952 R 209 (CUSIP Number) Robert L. Montgomery, Chief Executive Officer 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63005 (636)537-9715 (Name, Address

RELV / Reliv' International, Inc. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

Financial Statements and Exhibits, Results of Operations and Financial Condition

relv201711098k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2017 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-1993

Reliv International Reports Third-Quarter Financial Results for 2017

ex100008.htm Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results for 2017 CHESTERFIELD, MO, November 10, 2017 ? Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results fo

RELV / Reliv' International, Inc. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

Reliv International Reports Second-Quarter Financial Results for 2017

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results for 2017 CHESTERFIELD, MO, August 11, 2017 ? Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2017 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

Reliv' International 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 1

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2017 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

Reliv International Reports First-Quarter Financial Results for 2017

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2017 CHESTERFIELD, MO, May 12, 2017 ? Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 v4667448k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2017 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ I

Reliv' International DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28, 2017 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2016

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2016 CHESTERFIELD, MO, March 28, 2017 ? Reliv International, Inc.

Letter agreement between SL Technology, Inc. and Soy Labs, LLC dated September 2, 2016 (incorporated by reference to Exhibit 10.18 to the Form 10-K of the Registrant for the year ended December 31, 2016)

Exhibit 10.18 September 2, 2016 Dale R. Ludwig Managing Member Soy Labs, LLC 1150 Highway 50 West Linn, Missouri 65051 Dear Mr. Ludwig: This letter confirms and sets forth the terms of the agreement between Soy Labs, LLC (“Soy Labs”) and SL Technology, Inc. (“SLTI”) with respect to the assignment to SLTI of certain technology owned by Soy Labs and licensed by SLTI pursuant to that certain Technolo

Reliv International, Inc. Subsidiaries of Registrant1

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2016

10-K 1 v46186110k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2016 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ¨ TRANSITIO

Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.2 to the Form 10-K of the Registrant for the year ended December 31, 2016)

Exhibit 3.2 State of Delaware Secretary of State Division of Corporations Delivered 12:05 PM 09/30/2016 FILED 12:05 PM 09/30/2016 SR 20166015054 - File Number 3028773 CERTIFICATE OF AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF RELIV’ INTERNATIONAL, INC. Pursuant to the provisions of the Delaware General Corporation Law, Reliv’ International, Inc., a Delaware corpora

Reliv' International PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

RELV / Reliv' International, Inc. / Montgomery Robert L - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 RELIV INTERNATIONAL INC. (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 75952 R 100 (CUSIP Number) Robert L. Montgomery, Chief Executive Officer 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63005 (636)537-9715 (Name, Address

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2016 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commi

First Amendment to Loan Agreement dated September 30, 2016 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.1 to the Form 10-Q of the Registrant filed November 14, 2016).

EX-10.1 2 v452060ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 FIRST AMENDMENT TO LOAN AGREEMENT Principal Loan Date Maturity Loan No Call / Coll Account Officer Initials $3,500,000.00 09-30-2016 04-30-2018 8197223 UG *** References in the boxes above are for Lender's use only and do not limit the applicability of this document to any particular loan or item. Any item above containing "***" has been omitte

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

Change in Terms Agreement (revolving credit facility) dated September 30, 2016 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.2 to the Form 10-Q of the Registrant filed November 14, 2016).

Exhibit 10.2 CHANGE IN TERMS AGREEMENT Principal Loan Date Maturity Loan No Call / Coll Account Officer Initials $3,500,000.00 09-30-2016 04-30-2018 8197223 UG *** References in the boxes above are for Lender's use only and do not limit the applicability of this document to any particular loan or item. Any item above containing "***" has been omitted due to text length limitations. Borrower: RELIV

Reliv International Reports Third-Quarter Financial Results for 2016

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results for 2016 CHESTERFIELD, MO, November 11, 2016 ? Reliv International, Inc.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2016 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Comm

Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2016 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Comm

Reliv International Announces Reverse Stock Split

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Announces Reverse Stock Split CHESTERFIELD, MO, September 15, 2016 ? Reliv International, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2016 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

Reliv International Reports Second-Quarter Financial Results for 2016

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results for 2016 CHESTERFIELD, MO, August 12, 2016 ? Reliv International, Inc.

Reliv International Reports Second-Quarter Financial Results for 2016

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results for 2016 CHESTERFIELD, MO, August 12, 2016 ? Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2016 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

Reliv' International FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILARY PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION

Submission of Matters to a Vote of Security Holders

8-K 1 v4411498k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2016 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV? I

Reliv International Reports First-Quarter Financial Results for 2016

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2016 CHESTERFIELD, MO, May 13, 2016 ? Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2016 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2016 RELIV? INTERNATIONAL, INC.

Reliv' International DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State

Reliv' International PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2015

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2015 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2016 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

Reliv International, Inc. Subsidiaries of Registrant1

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2015

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2015 CHESTERFIELD, MO, March 24, 2016 ? Reliv International, Inc.

RELV / Reliv' International, Inc. / Montgomery Robert L - SC 13D Activist Investment

SC 13D 1 v430454sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 RELIV INTERNATIONAL INC. (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 75952 R 100 (CUSIP Number) Robert L. Montgomery, Chief Executive Officer 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63

Deed of Trust dated September 30, 2015 between Reliv International, Inc. as Grantor and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.4 to the Form 10-Q of the Registrant filed November 13, 2015).

Exhibit 10.4 DEED OF TRUST WITH FUTURE ADVANCES AND FUTURE OBLIGATIONS GOVERNED BY SECTION 443.055 RSMO THE TOTAL PRINCIPAL AMOUNT OF ALL OBLIGATIONS SECURED IS $6,100,000.00 MAXIMUM LIEN. The total principal amount of obligations at any one time which is secured by this Deed of Trust, in addition to any interest and any amounts advanced by Lender for the protection of the security interests grant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

Reliv International Reports Third-Quarter Financial Results

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results CHESTERFIELD, MO, November 13, 2015 ? Reliv International, Inc.

Promissory Note (term loan) dated September 30, 2015 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.1 to the Form 10-Q of the Registrant filed November 13, 2015).

Exhibit 10.1 PROMISSORY NOTE Principal Loan Date Maturity Loan No Call / Coll Account Officer Initials $3,249,500.74 09-30-2015 09-30-2018 8197231 1E / 59 *** References in the boxes above are for Lender's use only and do not limit the applicability of this document to any particular loan or item. Any item above containing "***" has been omitted due to text length limitations. Borrower: RELIV' INT

Promissory Note (revolving credit facility) dated September 30, 2015 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.2 to the Form 10-Q of the Registrant filed November 13, 2015).

Exhibit 10.2 PROMISSORY NOTE Principal Loan Date Maturity Loan No Call / Coll Account Officer Initials $3,500,000.00 09-30-2015 09-30-2016 8197223 1E / 59 *** References in the boxes above are for Lender's use only and do not limit the applicability of this document to any particular loan or item. Any item above containing "***" has been omitted due to text length limitations. Borrower: RELIV' INT

Business Loan Agreement dated September 30, 2015 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.3 to the Form 10-Q of the Registrant filed November 13, 2015).

Exhibit 10.3 BUSINESS LOAN AGREEMENT Principal Loan Date Maturity Loan No Call / Coll Account Officer Initials $3,249,500.74 09-30-2015 09-30-2018 8197231 1E / 59 *** References in the boxes above are for Lender's use only and do not limit the applicability of this document to any particular loan or item. Any item above containing "***" has been omitted due to text length limitations. Borrower: RE

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2015 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commi

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2015 RELIV? INTERNATIONAL, INC.

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2015 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Comm

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2015 RELIV INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-19932 37-1172197 (State or other jurisdiction (Commission (IRS Employer o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

Reliv International Reports Second-Quarter Financial Results

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results CHESTERFIELD, MO, August 14, 2015 ? Reliv International, Inc.

Reliv' International FORM 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2015 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

Reliv' International FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILARY PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2015 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

BY-LAWS OF RELIV’ INTERNATIONAL, INC. ARTICLE I — OFFICES

Exhibit 3.2 BY-LAWS OF RELIV? INTERNATIONAL, INC. ARTICLE I ? OFFICES SECTION 1. REGISTERED OFFICE. ?The registered office shall be established and maintained at CSC, 1013 Centre Road, City of Wilmington in the County of New Castle in the State of Delaware. SECTION 2. OTHER OFFICES. ?The corporation may have other offices, either within or without the State of Delaware, at such place or places as

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ I

Reliv International Reports First-Quarter Financial Results for 2015

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2015 CHESTERFIELD, MO, April 30, 2015 ? Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2015 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

Reliv' International FORM DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2015 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

AMENDED AND RESTATED ARTICLE IX INDEMNIFICATION OF OFFICERS, DIRECTORS, EMPLOYEES AND AGENTS

EXHIBIT 3.1 AMENDED AND RESTATED ARTICLE IX INDEMNIFICATION OF OFFICERS, DIRECTORS, EMPLOYEES AND AGENTS SECTION 1. The corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2014 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13

Reliv International, Inc. Subsidiaries of Registrant1

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

SECOND AMENDMENT TO CREDIT AGREEMENT

Exhibit 10.1 SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?) is made and entered into effective as of March 4, 2015, by and among Reliv? International, Inc., a Delaware corporation, Reliv?, Inc., an Illinois corporation, Reliv? World corporation, an Illinois corporation, and SL Technology, Inc., a Missouri corporation (each a ?Borrower? and collect

Current Report

8-K 1 v4039048k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2015 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 00

February 27, 2015

Exhibit 10.2 February 27, 2015 Mr. Steven D. Albright Senior Vice President / Chief Financial Officer Reliv International, Inc. P.O. Box 405 Chesterfield, Mo 63005 Re: Loan Agreement dated February 28, 2014; (the ?Loan Agreement?), by and between Reliv International, Inc.; Reliv Inc.; Reliv World Corporation, and SL Technology, Inc.; (?Borrower?), and BMO Harris Bank N.A. (?Lender?). Capitalized t

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2014

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2014 CHESTERFIELD, MO, March 4, 2015 – Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2015 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

RELV / Reliv' International, Inc. / Montgomery Robert L - SC 13D Activist Investment

SC 13D 1 v399367sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 RELIV INTERNATIONAL INC. (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 75952 R 100 (CUSIP Number) Robert L. Montgomery, Chief Executive Officer 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63

RELV / Reliv' International, Inc. S-8 - - S-8

Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RELIV’ INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Its Charter) DELAWARE 37-1172197 (State of Incorporation) (I.R.S. Employer Identification Number) 136 Chesterfield Industrial Boulevard Chesterfield, Missouri 63005 (636) 5

2014 Incentive Stock Plan (incorporated by reference to Exhibit 10.1 to the Form S-8 Registration Statement the Registrant filed November 19, 2014).

Exhibit 10.1 2014 INCENTIVE STOCK PLAN SECTION 1 General Purpose of the Plan; Definitions The name of the plan is the Reliv International, Inc. 2014 Incentive Stock Plan (the “Plan”). The purpose of the Plan is to encourage and enable officers and employees of, and other persons providing services to, Reliv International, Inc. (the “Company”) and its Affiliates to acquire a proprietary interest in

POWER OF ATTORNEY REGISTRATION STATEMENT ON FORM S-8 RELIV’ INTERNATIONAL, INC.

Exhibit 24 POWER OF ATTORNEY REGISTRATION STATEMENT ON FORM S-8 RELIV’ INTERNATIONAL, INC.

Form of RELIV’ INTERNATIONAL, INC. RESTRICTED STOCK AGREEMENT

Exhibit 10.4 Form of RELIV’ INTERNATIONAL, INC. RESTRICTED STOCK AGREEMENT THIS RESTRICTED STOCK AGREEMENT, made and entered into this day of , 20, between Reliv’ International, Inc. (hereinafter the “Company”), and (hereinafter “Employee”). WHEREAS, the Company has employed Employee and continues to employ Employee as of this date; and WHEREAS, the Company, as a further incentive to Employee to d

Form of RELIV' INTERNATIONAL, INC. INCENTIVE STOCK OPTION AGREEMENT

Exhibit 10.2 Form of RELIV' INTERNATIONAL, INC. INCENTIVE STOCK OPTION AGREEMENT 1. Grant of Option This Incentive Stock Option Agreement constitutes and evidences the grant by Reliv International, Inc. (the “Company”) on (the “Grant Date”) to , an employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2014 Ince

Form of RELIV’ INTERNATIONAL, INC. NON-STATUTORY STOCK OPTION AGREEMENT

Exhibit 10.3 Form of RELIV’ INTERNATIONAL, INC. NON-STATUTORY STOCK OPTION AGREEMENT 1. Grant of Option This Incentive Stock Option Agreement constitutes and evidences the grant by Reliv International, Inc. (the “Company”) on (the “Grant Date”) to , an employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

Reliv International Reports Third-Quarter Financial Results

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results CHESTERFIELD, MO, October 30, 2014 – Reliv International, Inc.

FIRST AMENDMENT TO CREDIT AGREEMENT

Exhibit 10.1 FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into effective as of October 29, 2014, by and among Reliv’ International, Inc., a Delaware corporation, Reliv’, Inc., an Illinois corporation, Reliv’ World corporation, an Illinois corporation, and SL Technology, Inc., a Missouri corporation (each a “Borrower” and collec

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2014 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2014 RELIV INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-19932 37-1172197 (State or other jurisdiction (Commission (IRS Employer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

Reliv International Reports Second-Quarter Financial Results

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results CHESTERFIELD, MO, July 31, 2014 – Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2014 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

- FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILARY PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ I

Reliv International Reports First-Quarter Financial Results for 2014

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2014 CHESTERFIELD, MO, April 30, 2014 – Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2014 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2014 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

Carl W. Hastings Employment Agreement dated March 31, 2014 (incorporated by reference to Exhibit 10.1 to the Form 8-K of the Registrant filed April 3, 2014).

EXHIBIT 10.1 E M P L O Y M E N T A G R E E M E N T THIS AGREEMENT is made and entered into this 31st day of March, 2014, effective from January 1, 2013 and for the term provided herein, by and between Reliv' International, Inc., a Delaware corporation (the "Company") and Carl W. Hastings (hereinafter referred to as the "Executive"). WHEREAS, the Executive is presently, and for some time has been,

Reliv International, Inc. Subsidiaries of Registrant1

EX-21 2 v371506ex21.htm EXHIBIT 21 Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of N

ANNUAL REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2013 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13

IMAGE OMITTED Credit Agreement dated as of February 28, 2014, Reliv’ International, Inc., Reliv’, Inc., Reliv’ World Corporation, and SL Technology, Inc., as Borrowers BMO Harris Bank N.A. SECTION 1. Table of Contents

Exhibit 10.1 IMAGE OMITTED Credit Agreement dated as of February 28, 2014, among Reliv’ International, Inc., Reliv’, Inc., Reliv’ World Corporation, and SL Technology, Inc., as Borrowers and BMO Harris Bank N.A. SECTION 1. Table of Contents SECTION 1. DEFINITIONS; INTERPRETATION. 1 Section 1.1 Definitions 1 Section 1.2 Interpretation 11 Section 1.3 Change in Accounting Principles.. 11 SECTION 2. T

- 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2014 RELIV INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-19932 37-1172197 (State or other jurisdiction (Commission (IRS Employer

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2014 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2013

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2013 CHESTERFIELD, MO, March 5, 2014 – Reliv International, Inc.

RELV / Reliv' International, Inc. / Montgomery Robert L - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 RELIV INTERNATIONAL INC. (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 75952 R 100 (CUSIP Number) Robert L. Montgomery, Chief Executive Officer 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63005 (636)537-9715 (Name, Address

- 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2013 RELIV INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware 1-11768 37-1172197 (State or other jurisdiction (Commission (IRS Employer o

Commission File Number

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

Reliv International Reports Third-Quarter Financial Results

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results CHESTERFIELD, MO, October 31, 2013 – Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

Reliv International Reports Second-Quarter Financial Results

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results CHESTERFIELD, MO, August 1, 2013 – Reliv International, Inc.

Agreement by and among Reliv International, Inc., SL Technology, Inc., Soy Labs, LLC and 1Soy, Inc. dated July 23, 2013 (incorporated by reference to Exhibit 10.2 to the Form 8-K of the Registrant filed July 25, 2013).

Exhibit 10.2 AGREEMENT THIS AGREEMENT is made and entered into this 23rd day of July, 2013, by and among Reliv International, Inc., a Delaware corporation (“Reliv”), Soy Labs, LLC, a Missouri limited liability company (“Soy Labs”), SL Technology, Inc., a Missouri corporation (“SL”) and 1Soy, Inc., a Missouri non-stock cooperative marketing association (“1Soy”). WHEREAS, concurrently with this Agre

Technology License Agreement by and between SL Technology, Inc. and Soy Labs, LLC dated July 23, 2013 (incorporated by reference to Exhibit 10.1 to the Form 8-K of the Registrant filed July 25, 2013).

Exhibit 10.1 TECHNOLOGY LICENSE AGREEMENT This Technology License Agreement (“Agreement”) is made as of the 23rd day of July 2013 (“the Effective Date”) by and between SL Technology, Inc., a corporation duly organized and existing under the laws of the State of Missouri, having a principal place of business at 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63005 (hereinafter referre

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

Reliv Acquires Exclusive Rights to ‘Superfood’ Lunasin Deal positions Reliv as industry leader in emerging field of nutritional epigenetics

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv Acquires Exclusive Rights to ‘Superfood’ Lunasin Deal positions Reliv as industry leader in emerging field of nutritional epigenetics CHESTERFIELD, MO, July 24, 2013 – Reliv International, Inc.

- FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILARY PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ I

Reliv International Reports First-Quarter Financial Results for 2013

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Mark Murphy Chief Financial Officer Investor Relations Media Relations (636) 733-1305 (636) 733-1314 (636) 733-1391 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2013 CHESTERFIELD, Mo.

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2012 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 OR ? TRANSITION REPORT PURSUANT TO SECTION 13

Reliv International, Inc. Subsidiaries of Registrant1

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2012

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2012 CHESTERFIELD, Missouri, March 6, 2013 – Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

RELV / Reliv' International, Inc. / Montgomery Robert L - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 18)* Reliv International, Inc. (Name of Issuer) Common Stock, $.001 Par Value (Title of Class of Securities) 75952 R 100 (CUSIP Number) February 27, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2013 RELIV INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-19932 37-1172197 (State or other jurisdiction (Commission (IRS Employer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

Reliv International Reports Third-Quarter Financial Results

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results CHESTERFIELD, Missouri, October 31, 2012 – Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

EX-10.1

Exhibit 10.1

EX-10.2

v325022ex10-2 - Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing Exhibit 10.2

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Comm

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

Reliv International Reports Second-Quarter Financial Results

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results CHESTERFIELD, Missouri, August 1, 2012 – Reliv International, Inc.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

- FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILARY PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR ¨ TRANSITION REPORT PURSUANT TO SECTION

Submission of Matters to a Vote of Security Holders - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

Loan Sale Agreement between 2010-1 RADC/CADC Venture, LLC and Reliv International, Inc. dated March 16, 2012 (incorporated by reference to Exhibit 10.1 to the Form 10-Q of the Registrant for the quarter ended March 31, 2012).

Exhibit 10.1 LOAN SALE AGREEMENT This Loan Sale Agreement (this “Agreement”) is made effective as of March 16, 2012 (the “Effective Date”), between 2010-1 RADC/CADC Venture, LLC (“Seller”), and Reliv’ International, Inc. (“Buyer”). Recitals A. Seller is the current owner and holder of a loan (the “Loan”) evidenced by (among other things) the following documents (collectively, the “Loan Documents”)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ I

Reliv International Reports First-Quarter Financial Results for 2012

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2012 CHESTERFIELD, Missouri, May 2, 2012 – Reliv International, Inc.

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 v3115578k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2011

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2011 (Mark One) S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR £ TRANSITION REPORT PURSUANT TO SECTION 13

Reliv International, Inc. Subsidiaries of Registrant1

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commi

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2011

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2011 CHESTERFIELD, Missouri, February 29, 2012 – Reliv International, Inc.

RELV / Reliv' International, Inc. / Montgomery Robert L Passive Investment

SC 13G/A 1 v302067sc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 17)* Reliv International, Inc. (Name of Issuer) Common Stock, $.001 Par Value (Title of Class of Securities) 75952 R 100 (CUSIP Number) February 10, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropria

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2011 RELIV’ INTERNATI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2011 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

Reliv International Reports Third-Quarter Financial Results

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results CHESTERFIELD, Missouri, November 2, 2011 ? Reliv International, Inc.

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2011 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

EX-10.1

Exhibit 10.1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN